Devonian Health Group, Inc. (TSE:GSD) has released an update.
Devonian Health Group Inc., a botanical pharmaceutical company, has strengthened its board by appointing Kathryn J. Gregory, a seasoned pharmaceutical and biotech executive with over 25 years of experience. Gregory’s extensive background in business development and corporate strategy is expected to bolster Devonian’s clinical program advancement and commercialization efforts. Additionally, the company has granted 50,000 stock options to a director, subject to regulatory approval.
For further insights into TSE:GSD stock, check out TipRanks’ Stock Analysis page.
